Skip to main content
. 2017 Nov 13;7:15443. doi: 10.1038/s41598-017-15749-z

Figure 1.

Figure 1

WBSCR22 gene was over-expressed and predicted a poor clinical outcome in human CRC of the TCGA cohort. (A) The expression of WBSCR22 in 348 clinical CRC specimens in the TCGA cohort. The red bars represented CRC samples having a more than 2-fold higher WBSCR22 expression than normal samples. (B) WBSCR22 levels were compared between normal samples and different NMT stages of CRC samples. A single spot represented the WBSCR22 expression value of an individual sample, and the results were expressed as the mean ± SE. ***p < 0.001. (C) Kaplan-Meier survival curves were plotted according to the different WBSCR22 mRNA level of all CRC patients. p values were obtained from log-rank test, while hazard ratio (HR) and 95% confidence interval (CI) were determined by univariate Cox regression model.